Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
SYRE compared with TNGX: revenue, margins and what each company keeps, and the suppliers and customers both name
SYRE
Spyre Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
TNGX
Tango Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
SYRE
Spyre Therapeutics, Inc.
vs
TNGX
Tango Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
SYRE, solid
TNGX, dashed
Supply-chain overlap
Revenue flow
SYRE: latest quarter not drawable.
Method
›
SYRE
Spyre Therapeutics, Inc.
Change
96.44
▼
−2.55%
Mkt cap
$8.5B
Revenue
—
Revenue
—
TNGX
Tango Therapeutics, Inc.
Change
22.72
▲
+0.84%
· post 22.72
Closed
Oct 30 '26
Mkt cap
$3.8B
Revenue
$54M
Q3 FY25
Revenue
$42M
FY24
vs
Compare
Closed
Oct 30 '26
SYRE
Spyre Therapeutics, Inc.
vs
TNGX
Tango Therapeutics, Inc.
96.44
▼
−2.55%
Price
22.72
▲
+0.84%
post 22.72
$8.5B
Mkt cap
$3.8B
—
Revenue
$54M
Q3 FY25
—
Revenue
$42M
FY24
Change
Change
SYRE
96.44
▼
−2.55%
vs
TNGX
22.72
▲
+0.84%
Closed
Oct 30 '26
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only SYRE
5
—
WuXi Biologics (Hong Kong)
unlisted
supplier
—
Paragon
unlisted
supplier
—
WuXi Biologics
unlisted
supplier
—
Equiniti Trust Company LLC (f/k/a American Stock Transfer & Trust Company LLC)
unlisted
supplier
1 more · SYRE chain
›
Shared
0
No shared counterparties.
Only TNGX
1
—
WuXi AppTec
unlisted
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR